Electrical Impedance Tomography in Fatty Liver Detection

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIAGNOSTIC_TEST

Electrical impedance tomography

Fatty liver patients will be recruited from the Department of Medicine at Queen Mary Hospital. Gender- and age- matched control subjects will be publicly recruited. Subjects will undergo the EIT-liver scan and FibroScan®. Selected subgroups will also undergo MRI-PDFF scan. The performance characteristics of the device and with respect to Fibroscan/ MRI-PDFF for liver fat quantification will be assessed.

Trial Locations (1)

0000

The University of Hong Kong, Hong Kong

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gense Technologies Ltd.

UNKNOWN

collaborator

Innovation and Technology Commission, Hong Kong

OTHER

lead

The University of Hong Kong

OTHER